Literature DB >> 31314718

Pseudomyxoma Peritonei-An Unusual Cause of Ascites: A Case Report.

Puneet Chhabra1, Sushant Soni2, Hunny Khurana3.   

Abstract

INTRODUCTION: Ascites in patients with cardiac disease can be multifactorial. Serum ascitic albumin gradient (SAAG) helps in identifying the etiology of ascites. High SAAG ascites is related to hepatic or posthepatic causes. The causes of low SAAG ascites results include tuberculosis, peritoneal malignancy, or pancreatitis. CASE
PRESENTATION: We report an unusual cause of low SAAG ascites in a 48-year-old woman with valvular heart disease. The patient presented with ascites, and cross-sectional imaging revealed a right iliac fossa mass with omental deposits. The patient was finally diagnosed as having pseudomyxoma peritonei on the basis of clinicoradiopathological features. DISCUSSION: Pseudomyxoma peritonei is a rare cause of low SAAG ascites. It is characterized by the deposition of mucinous material on the peritoneal surfaces. The most common site of origin is the appendix, although it can arise from other intraabdominal organs as well. Excision of the tumor combined with intraperitoneal chemotherapy is the preferred modality of treatment.

Entities:  

Year:  2019        PMID: 31314718      PMCID: PMC6636538          DOI: 10.7812/TPP/18-114

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  14 in total

1.  Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture.

Authors:  P H Sugarbaker
Journal:  Can J Surg       Date:  1989-05       Impact factor: 2.089

2.  Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.

Authors:  P H Sugarbaker
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

Review 3.  Pseudomyxoma peritonei: a review of current literature.

Authors:  D M Sherer; O Abulafia; R Eliakim
Journal:  Gynecol Obstet Invest       Date:  2001       Impact factor: 2.031

4.  The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome.

Authors:  John Spiliotis; Elias Efstathiou; Evgenia Halkia; Archodoula Vaxevanidou; Anastasios Datsis; Paul Sugarbaker
Journal:  Hepatogastroenterology       Date:  2012-05

Review 5.  Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis.

Authors:  Katherine McBride; David McFadden; Turner Osler
Journal:  J Surg Res       Date:  2013-01-10       Impact factor: 2.192

Review 6.  The etiology, clinical presentation, and management of pseudomyxoma peritonei.

Authors:  Brendan J Moran; Thomas D Cecil
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

7.  Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology.

Authors:  Cyril Omohwo; Carol A Nieroda; Kimberley D Studeman; Heather Thieme; Paula Kostuik; Alexander S Ross; Darlene R Holter; Vadim Gushchin; Barry Merriman; Armando Sardi
Journal:  J Am Coll Surg       Date:  2009-07-09       Impact factor: 6.113

8.  CT in pseudomyxoma peritonei: a review of 17 cases.

Authors:  T V C Sulkin; H O'Neill; A I Amin; B Moran
Journal:  Clin Radiol       Date:  2002-07       Impact factor: 2.350

Review 9.  Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence.

Authors:  A Mukherjee; A Parvaiz; T D Cecil; B J Moran
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

10.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.

Authors:  R M Smeenk; M L F van Velthuysen; V J Verwaal; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2007-05-23       Impact factor: 4.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.